TACE-HAIC Plus Lenvatinib for Patients With Unresectable HCC: an Open-label, Single-arm, Phase 2 Trial
Clinical trial NCT04531228 · UNKNOWN
Trial details
- NCT number
- NCT04531228
- Sponsor
- Yunfei Yuan
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-11
- Primary completion
- 2023-04-30
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.